Literature DB >> 9686348

Alternative pathway therapy for urea cycle disorders.

F Feillet1, J V Leonard.   

Abstract

In man the major pathway for the disposal of waste nitrogen is the urea cycle; in inborn errors of this pathway, nitrogen flux is reduced. As a result there is accumulation of ammonia and glutamine with disordered metabolism of other amino acids. Nitrogen homeostasis can be restored in these patients with a low-protein diet combined with compounds that create alternative pathways for nitrogen excretion. The introduction of these compounds has been a major advance in the management of these inborn errors and as a result the outcome, particularly for those treated early, has improved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9686348     DOI: 10.1023/a:1005365825875

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  38 in total

1.  Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency.

Authors:  Y Ohtani; K Ohyanagi; S Yamamoto; I Matsuda
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

Review 2.  The biochemistry and toxicology of benzoic acid metabolism and its relationship to the elimination of waste nitrogen.

Authors:  G C Tremblay; I A Qureshi
Journal:  Pharmacol Ther       Date:  1993-10       Impact factor: 12.310

3.  Evidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies.

Authors:  M L Batshaw; S W Brusilow
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

4.  Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.

Authors:  L Ratnakumari; I A Qureshi; R F Butterworth
Journal:  Metabolism       Date:  1993-08       Impact factor: 8.694

5.  Increased tryptophan uptake into the brain in hyperammonemia.

Authors:  C Bachmann; J P Colombo
Journal:  Life Sci       Date:  1983-12-12       Impact factor: 5.037

6.  Inhibition of pyruvate carboxylase by sequestration of coenzyme A with sodium benzoate.

Authors:  A D Griffith; D M Cyr; S G Egan; G C Tremblay
Journal:  Arch Biochem Biophys       Date:  1989-02-15       Impact factor: 4.013

7.  Brain uptake of tryptophan in urease-injected hyperammonemic rats after treatment with benzoate or hippurate.

Authors:  C Bachmann; H Lüthi; M Gradwohl; J P Colombo
Journal:  Biochem Med Metab Biol       Date:  1986-10

8.  Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia.

Authors:  L Ratnakumari; I A Qureshi; R F Butterworth
Journal:  Biochem Pharmacol       Date:  1993-01-07       Impact factor: 5.858

9.  Carbamyl glutamate prevents the potentiation of ammonia toxicity by sodium benzoate.

Authors:  J E O'Connor; M Costell; S Grisolía
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

10.  Effect of single oral dose of sodium benzoate on ureagenesis in healthy men and two patients with late onset citrullinaemia.

Authors:  K Kubota; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more
  22 in total

Review 1.  Ornithine carbamoyltransferase deficiency.

Authors:  J E Wraith
Journal:  Arch Dis Child       Date:  2001-01       Impact factor: 3.791

2.  Long-term outcome and intervention of urea cycle disorders in Japan.

Authors:  Jun Kido; Kimitoshi Nakamura; Hiroshi Mitsubuchi; Toshihiro Ohura; Masaki Takayanagi; Masafumi Matsuo; Makoto Yoshino; Yosuke Shigematsu; Tohru Yorifuji; Mureo Kasahara; Reiko Horikawa; Fumio Endo
Journal:  J Inherit Metab Dis       Date:  2011-12-14       Impact factor: 4.982

3.  Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment.

Authors:  Jun Kido; Shirou Matsumoto; Hiroshi Mitsubuchi; Fumio Endo; Kimitoshi Nakamura
Journal:  Metab Brain Dis       Date:  2018-06-11       Impact factor: 3.584

Review 4.  Clinical practice: the management of hyperammonemia.

Authors:  Johannes Häberle
Journal:  Eur J Pediatr       Date:  2010-12-17       Impact factor: 3.183

5.  Detection of neonatal argininosuccinate lyase deficiency by serum tandem mass spectrometry.

Authors:  S Stadler; K Gempel; I Bieger; B F Pontz; K D Gerbitz; M F Bauer; S Hofmann
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

Review 6.  Ornithine phenylacetate revisited.

Authors:  Maria Jover-Cobos; Lorette Noiret; Yalda Sharifi; Rajiv Jalan
Journal:  Metab Brain Dis       Date:  2013-03-02       Impact factor: 3.584

7.  Amino acids in CSF and plasma in hyperammonaemic coma due to arginase1 deficiency.

Authors:  S Scholl-Bürgi; S Baumgartner Sigl; J Häberle; E Haberlandt; K Rostásy; C Ertl; U Eichinger-Öttl; P Heinz-Erian; D Karall
Journal:  J Inherit Metab Dis       Date:  2008-12-06       Impact factor: 4.982

8.  Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency.

Authors:  S E Raper; J M Wilson; M Yudkoff; M B Robinson; X Ye; M L Batshaw
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

9.  Hyperammonaemia as a cause of psychosis in an adolescent.

Authors:  Amaya Bélanger-Quintana; Mercedes Martínez-Pardo; María José García; Bendicht Wermuth; Julián Torres; Esperanza Pallarés; Magdalena Ugarte
Journal:  Eur J Pediatr       Date:  2003-08-27       Impact factor: 3.183

10.  Clinical manifestations and growth of patients with urea cycle disorders in Japan.

Authors:  Kimitoshi Nakamura; Jun Kido; Shirou Matsumoto; Hiroshi Mitsubuchi; Fumio Endo
Journal:  J Hum Genet       Date:  2016-03-03       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.